Article
Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
PloS one - 1 Jan 2013
Loureiro Jesús, Sandoval Pilar, del Peso Gloria, Gónzalez-Mateo Guadalupe, Fernández-Millara Vanessa, Santamaria Beatríz, Bajo Maria Auxiliadora, Sánchez-Tomero José Antonio, Guerra-Azcona Gonzalo, Selgas Rafael, López-Cabrera Manuel, Aguilera Abelardo I
Abstract excerpt
Mesothelial-to-mesenchymal transition (MMT) is an auto-regulated physiological process of tissue repair that in uncontrolled conditions such as peritoneal dialysis (PD) can lead to peritoneal fibrosis. The maximum expression of peritoneal fibrosis induced by PD fluids and other peritoneal processes is the encapsulating peritoneal sclerosis (EPS) for which no specific treatment exists. Tamoxifen, a synthetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
